Cargando…
Synucleinopathy in Amyotrophic Lateral Sclerosis: A Potential Avenue for Antisense Therapeutics?
Amyotrophic lateral sclerosis (ALS) is the most common adult-onset motor neuron disease classified as both a neurodegenerative and neuromuscular disorder. With a complex aetiology and no current cure for ALS, broadening the understanding of disease pathology and therapeutic avenues is required to pr...
Autores principales: | Roberts, Bradley, Theunissen, Frances, Mastaglia, Francis L., Akkari, P. Anthony, Flynn, Loren L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409035/ https://www.ncbi.nlm.nih.gov/pubmed/36012622 http://dx.doi.org/10.3390/ijms23169364 |
Ejemplares similares
-
Association of a structural variant within the SQSTM1 gene with amyotrophic lateral sclerosis
por: Pytte, Julia, et al.
Publicado: (2020) -
Novel STMN2 Variant Linked to Amyotrophic Lateral Sclerosis Risk and Clinical Phenotype
por: Theunissen, Frances, et al.
Publicado: (2021) -
New perspectives on cytoskeletal dysregulation and mitochondrial mislocalization in amyotrophic lateral sclerosis
por: Theunissen, Frances, et al.
Publicado: (2021) -
Intronic NEFH variant is associated with reduced risk for sporadic ALS and later age of disease onset
por: Theunissen, Frances, et al.
Publicado: (2022) -
Antisense oligonucleotide silencing of FUS expression as a therapeutic approach in amyotrophic lateral sclerosis
por: Korobeynikov, Vladislav A., et al.
Publicado: (2022)